Supplementary Figure 1.

2
Supplementary Figure 1. B D1-2 NoInf D1-2 Inf D3-4 NoInf D3-4 Inf 0 50 100 150 200 sCD127 concentration (ng/ml) p < 0.001 IL-7 Concentration (pg / mL) D1-2 D3-4 HV 0 10 20 30 p < 0.001 A

description

Supplementary Figure 1. A. 30. p < 0.001. p < 0.001. 20. IL-7 Concentration ( pg / mL ). 10. 0. D1-2. D3-4. HV. B. 200. 150. 100. sCD127 concentration ( ng /ml). 50. 0. D1-2 NoInf. D1-2 Inf. D3-4 NoInf. D3-4 Inf. Supplementary Figure 2. - PowerPoint PPT Presentation

Transcript of Supplementary Figure 1.

Page 1: Supplementary Figure 1.

Supplementary Figure 1.

B

D1-2 NoInf

D1-2 Inf

D3-4 NoInf

D3-4 Inf

0

50

100

150

200

sCD

127

conc

entr

ation

(ng/

ml)

p < 0.001

IL-7

Con

cent

ratio

n (p

g /

mL)

D1-2 D3-4 HV0

10

20

30

p < 0.001

A

Page 2: Supplementary Figure 1.

A. Survival curves based on sCD127 (D1) and SAPSII

0 10 20 300

20

40

60

80

100

Days

Perc

ent s

urvi

val

sCD127 ≤ 48.78 - SAPSII ≤ 59

sCD127 ≤ 48.78 - SAPSII > 59

sCD127 > 48.78 - SAPSII > 59

sCD127 > 48.78 - SAPSII ≤ 59

sCD127 ≤ 41.56 - SAPSII ≤ 59

sCD127 ≤ 41.56 - SAPSII > 59

sCD127 > 41.56 - SAPSII > 59

sCD127 > 41.56 - SAPSII ≤ 59

0 10 20 300

20

40

60

80

100

Days

Perc

ent s

urvi

val

B. Survival curves based on sCD127 (D3) and SAPSII

Supplementary Figure 2.